About Pharmerit_WPadmin

This author has not yet filled in any details.
So far Pharmerit_WPadmin has created 195 blog entries.

Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin

Quality-adjusted Outcomes Stratified by Response in Patients With Advanced Non-Small-cell Lung Cancer Receiving First-line nab-Paclitaxel/Carboplatin or Paclitaxel/Carboplatin Background First-line nab-paclitaxel/carboplatin was associated with a significantly improved overall response rate (primary [...]

2018-06-29T06:15:19+00:00 June 29th, 2018|

Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Adenocarcinoma: Australian Subset Analyses of the Phase III MPACT Trial

Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Adenocarcinoma: Australian Subset Analyses of the Phase III MPACT Trial Aim The phase III MPACT trial (N = 861) demonstrated superior overall survival (OS) with first-line [...]

2018-07-24T10:08:26+00:00 June 26th, 2018|

Performance Status Dynamics During Treatment with Nab-paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Metastatic Pancreatic Cancer

Performance Status Dynamics During Treatment with Nab-paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Metastatic Pancreatic Cancer Objectives This analysis examined changes in Karnofsky performance status (KPS) as a surrogate for [...]

2018-07-24T10:10:06+00:00 June 25th, 2018|

Kelly McCarrier will join Pharmerit as Director and US Qualitative Lead within the Patient-Reported Outcomes and Clinical Outcomes Assessment Center of Excellence

Pharmerit International is pleased to welcome Kelly McCarrier, who will join Pharmerit as Director and US Qualitative Lead within the Patient-Reported Outcomes and Clinical Outcomes Assessment Center of Excellence. In this role, Kelly will serve as a leader in the [...]

2018-06-13T12:26:35+00:00 June 13th, 2018|

Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies

Real-world Outcomes of Multiple Myeloma: Retrospective Analysis of the Czech Registry of Monoclonal Gammopathies Introduction Real-world data on patient outcomes and treatment patterns in multiple myeloma (MM) are limited. [...]

2018-06-14T12:56:03+00:00 June 13th, 2018|

Pharmerit Partners with AMCP Foundation to Support the Boston Community

April 24, 2018 (Bethesda, MD) – Pharmerit International (Pharmerit), a leading health economics and outcomes research firm, has announced a partnership with the Academy of Managed Care Pharmacy (AMCP) Foundation. Pharmerit will provide support for the AMCP Foundation “Sock Charity” [...]

2018-05-09T15:57:48+00:00 April 23rd, 2018|